Indications for resection and radiosurgery for brain metastases

Area of Science:

• Neuro-oncology
• Radiation Oncology
• Surgical Oncology

Background:

• Brain metastases are a common complication in patients with extracranial solid cancers, affecting over 40% of cancer patients.
• Metastases can present as symptomatic large lesions or asymptomatic tumors detected via screening.
• Current management options include whole brain radiation therapy, surgical resection, and stereotactic radiosurgery.

Purpose of the Study:

• To review indications for resection, stereotactic radiosurgery, and fractionated radiotherapy in patients with single or multiple brain metastases.
• To summarize the effects of these management approaches on patient outcomes.
• To highlight the importance of multimodal therapy for improving quality of life and survival.

Main Methods:

• Literature review of publications from May 2004 to June 2005.
• Focus on studies evaluating the impact of different procedures and therapies on quality of life.
• Synthesis of evidence from randomized, class III clinical trials.

Main Results:

• Multimodal therapy is crucial for enhancing both quality of life and survival in patients with brain metastases.
• Available data provide insights into outcomes, survival rates, management morbidity, and quality of life associated with various treatment modalities.
• A comprehensive understanding of therapeutic options is essential for advancing patient care.

Conclusions:

• The review emphasizes the significance of a multimodal approach in managing brain metastases.
• Further understanding of treatment effects on quality of life is critical.
• Improved patient care can be achieved through better knowledge of current therapeutic strategies.